Correction to "A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy"
about
Correction to "A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy"
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Correction to "A Pt(IV) Pro-dr ...... an Cancer Immuno-Chemotherapy"
@en
type
label
Correction to "A Pt(IV) Pro-dr ...... an Cancer Immuno-Chemotherapy"
@en
prefLabel
Correction to "A Pt(IV) Pro-dr ...... an Cancer Immuno-Chemotherapy"
@en
P2093
P356
P1476
Correction to "A Pt(IV) Pro-dr ...... an Cancer Immuno-Chemotherapy"
@en
P2093
Michael T Hemann
Peter M Bruno
Samuel G Awuah
Stephen J Lippard
P356
10.1021/JACS.6B01316
P407
P577
2016-02-26T00:00:00Z